Activation of human cancer/testis antigen gene, XAGE‐1, in tumor cells is correlated with CpG island hypomethylation

Expression of the XAGE‐1 antigen is restricted to germ cells of the testis and a variety of neoplastic tissues. To date, the molecular mechanism for regulating expression of this cancer/testis antigen gene has been unknown. To evaluate methylation as a potential mechanism for regulating expression of this gene, we first correlated gene methylation status (measured by sequencing of bisulfide‐modified DNA and COBRA) to expression of XAGE‐1 mRNA in normal and cancerous cells. This analysis revealed dense methylation of the CpG island in the XAGE‐1 gene promoter for the normal and cancerous cells that do not express this gene but loss of this methylation in normal testis, cancer cell lines and the primary gastric cancers where the gene is highly expressed. Further supporting the role of methylation in regulating expression of XAGE‐1 were observations that treatment of 2 heavily methylated cell lines, SNU620 and HT29, with 5′‐aza‐deoxycytidine resulted in demethylation of XAGE‐1 promoter and corresponding expression of this gene. Finally, we cloned various segments of the CpG‐rich XAGE‐1 gene promoter linked to a luciferase reporter construct and transiently transfected this construct into HCT116 cells. These experiments confirmed transcriptional regulatory activity for the promoter region that incorporates the CpG island and demonstrated that in vitro methylation of this island results in loss of promoter activity. Collectively, these studies indicate that XAGE‐1 expression in normal and cancerous tissues is regulated by methylation of the CpG island in the gene promoter. © 2005 Wiley‐Liss, Inc.

[1]  G. V. van Muijen,et al.  Cancer/testis‐associated genes: Identification, expression profile, and putative function , 2003, Journal of cellular physiology.

[2]  Yao-Tseng Chen,et al.  Cancer/testis antigens: an expanding family of targets for cancer immunotherapy , 2002, Immunological reviews.

[3]  U. Weidle,et al.  The XAGE family of cancer/testis‐associated genes: Alignment and expression profile in normal tissues, melanoma lesions and Ewing's sarcoma , 2002, International journal of cancer.

[4]  I. Pastan,et al.  Characterization of overlapping XAGE-1 transcripts encoding a cancer testis antigen expressed in lung, breast, and other types of cancers. , 2002, Molecular cancer therapeutics.

[5]  A. D. den Hollander,et al.  Characterization of XAGE‐1b, a short major transcript of cancer/testis‐associated gene XAGE‐1, induced in melanoma metastasis , 2002, International journal of cancer.

[6]  M. Maio,et al.  Promoter Methylation Controls the Expression of MAGE2, 3 and 4 Genes in Human Cutaneous Melanoma , 2002, Journal of immunotherapy.

[7]  S. Reed,et al.  L552S, an alternatively spliced isoform of XAGE-1, is over-expressed in lung adenocarcinoma , 2001, Oncogene.

[8]  W. Hong,et al.  Activation of melanoma antigen tumor antigens occurs early in lung carcinogenesis. , 2001, Cancer research.

[9]  J. Herman,et al.  DNA methylation, chromatin inheritance, and cancer , 2001, Oncogene.

[10]  Y. Cao,et al.  Cytosine methylation of an Sp1 site contributes to organ-specific and cell-specific regulation of expression of the lung epithelial gene t1alpha. , 2000, The Biochemical journal.

[11]  I. Pastan,et al.  XAGE-1, a new gene that is frequently expressed in Ewing's sarcoma. , 2000, Cancer research.

[12]  K D Robertson,et al.  DNA methylation: past, present and future directions. , 2000, Carcinogenesis.

[13]  A. Bird,et al.  Methylation-Induced Repression— Belts, Braces, and Chromatin , 1999, Cell.

[14]  Y. Bang,et al.  Up‐regulation of human telomerase catalytic subunit during gastric carcinogenesis , 1999, Cancer.

[15]  I. Pastan,et al.  Novel genes in the PAGE and GAGE family of tumor antigens found by homology walking in the dbEST database. , 1999, Cancer research.

[16]  Peter A. Jones,et al.  The Human ARF Cell Cycle Regulatory Gene Promoter Is a CpG Island Which Can Be Silenced by DNA Methylation and Down-Regulated by Wild-Type p53 , 1998, Molecular and Cellular Biology.

[17]  S. Kudo.  Methyl-CpG-Binding Protein MeCP2 Represses Sp1-Activated Transcription of the Human Leukosialin Gene When the Promoter Is Methylated , 1998, Molecular and Cellular Biology.

[18]  J. Strouboulis,et al.  Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription , 1998, Nature Genetics.

[19]  Colin A. Johnson,et al.  Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex , 1998, Nature.

[20]  P. Jones,et al.  The role of DNA methylation in expression of the p19/p16 locus in human bladder cancer cell lines. , 1998, Cancer research.

[21]  K. Robertson,et al.  Mapping promoter regions that are hypersensitive to methylation-mediated inhibition of transcription: application of the methylation cassette assay to the Epstein-Barr virus major latency promoter , 1997, Journal of virology.

[22]  Stephen B. Baylin,et al.  Mapping Patterns of CpG Island Methylation in Normal and Neoplastic Cells Implicates Both Upstream and Downstream Regions inde Novo Methylation* , 1997, The Journal of Biological Chemistry.

[23]  P. Laird,et al.  COBRA: a sensitive and quantitative DNA methylation assay. , 1997, Nucleic acids research.

[24]  S. Cross,et al.  Purification of CpG islands using a methylated DNA binding column , 1994, Nature Genetics.

[25]  L. E. McDonald,et al.  A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[26]  P. Jones,et al.  Differential nuclear protein binding to 5-azacytosine-containing DNA as a potential mechanism for 5-aza-2'-deoxycytidine resistance , 1987, Molecular and cellular biology.

[27]  M. Frommer,et al.  CpG islands in vertebrate genomes. , 1987, Journal of molecular biology.

[28]  J. Christman,et al.  Inhibition of DNA methyltransferase and induction of Friend erythroleukemia cell differentiation by 5-azacytidine and 5-aza-2'-deoxycytidine. , 1982, The Journal of biological chemistry.